Home
Scholarly Works
PIN5 Serious Adverse Events In Canadian Children...
Conference

PIN5 Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus Infection

Authors

Chan P; Chen J; Paes B; Mitchell I; Li A; Lanctôt K

Volume

18

Pagination

pp. a228-a229

Publisher

Elsevier

Publication Date

May 1, 2015

DOI

10.1016/j.jval.2015.03.1329

Conference proceedings

Value in Health

Issue

3

ISSN

1098-3015

Contact the Experts team